Upload Avatar (500 x 500)
Huifang Dai
hfdai@fudan.edu.cn
English, Chinese
Shanghai
Fudan University
Pharmaceutical Sciences
  • 2011.06 – 2012.06 Postdoctoral: Stanford University, Department of Chemistry
  • 2011.01 – 2011.06 Postdoctoral: University of Wisconsin-Madison, School of Pharmacy
  • 2004.09 – 2009.01 Ph.D. in Organic Chemistry: Fudan University, Department of Chemistry
  • 1987.09 – 1991.07 Bachelor's in Chemistry: Zhejiang Normal University, Department of Chemistry
  • 2009.04 – Present - Fudan University, School of Pharmacy - Lecturer in Medicinal Chemistry
  • 2014.10 – Present - AuBrown PharmaTech Co. Ltd - Technical Director
  • 2018.08 – Present - Jiangsu Qidong Economic and Technological Development Zone - Deputy District Chief
  • 2012.06 – 2013.02 - University of California, Berkeley, Department of Chemistry/Bioenergy Institute - Research Associate III
  • 2001.09 – 2003.07 - Fudan University, Department of Environmental Science - Visiting Scholar
  • 1991.09 – 2001.07 - Zhejiang Jinhua Vocational and Technical College, School of Bioengineering - Lecturer
  • 2019: Commemorative Medal for the 70th Anniversary of the Founding of the People's Republic of China, Central Committee of the Communist Party of China, State Council, Central Military Commission
  • 2019: Excellent Award, Jiangsu Provincial Science and Technology Town Chief Group, Jiangsu Province
  • 2014: Leading Talent Honor of 'Double Dragon Talent' A-Class, Zhejiang Province
  • 2010: CSC Study Abroad Fund, China Scholarship Council
  • 2009: Excellent Doctoral Dissertation Award, Fudan University
  • 2008: Second Prize of the 5th Shanghai Invention Patent, Shanghai
  • 2007: Second Prize of National Science and Technology Progress Award (Second Place), State Council
  • 2004: First Prize of Science and Technology Progress Award (Second Place), Ministry of Education
  • 2003: National Excellent Teaching Paper Award, Ministry of Education
Research and development of green synthesis processes for industrial applications
Design, synthesis, and research of novel heterogeneous catalysts and chiral catalytic technologies
Research on new drug discovery based on active natural products
  • Synthesis, structure–activity relationships, and docking studies of N-phenylarylformamide derivatives (PAFAs) as non-nucleoside HIV reverse transcriptase inhibitors, Xiao-Dong Ma, Qiu-Qin He, Xuan Zhang, Shi-Qiong Yang, Liu-Meng Yang, Shuang-Xi Gu, Yong-Tang Zheng, Fen-Er Chen, Hui-Fang Dai, 2012
  • Asymmetric Aza-[3 t 3] Annulation in the Synthesis of Indolizidines: An Unexpected Reversal of Regiochemistry, Grant S. Buchanan, Huifang Dai, Richard P. Hsung, 2011
  • Design, synthesis and biological evaluation of cycloalkyl arylpyrimidines (CAPYs) as HIV-1 NNRTIs, Shuang-Xi Gu, Shi-Qiong Yang, Qiu-Qin He, Xiao-Dong Ma, Fen-Er Chen, Hui-Fang Dai, Erik De Clercqc, 2011
  • Efficient Asymmetric synthesis of (2R,3R)-3-{(1R)-1-[tert-Butyl(dimethyl)-siloxy]ethyl}-4-oxoazetidin-2-yl Acetate, Jian-Ping Huang, Lei Zhao, Shuang-Xi Gu, Hui-Fang Dai, 2011
  • Synthetic Studies on d-Biotin, Part 11): Application of Cinchona Alkaloid-Mediated Asymmetric Alcoholysis of meso-Cyclic Anhydride in the Total Synthesis of (+)-Biotin, H. F. Dai, F.E.Chen, 2008
Green Synthesis Industrial Applications Heterogeneous Catalysts Chiral Catalysis Natural Products Drug Discovery Synthesis Catalysis Research Development

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.